I wouldn't have named him ceo of the year. Maybe whomever heads up their molecular diagnostics division should be named executive of the year.
Best performer in biotech may have been qcor. ceo had the guts/nerve to raise his core products price by 1000%, they go from nearly bankrupt to throwing off $40M-50M/year in cash flow. Buy back 15% of their shares and the stock is up many fold.